cip1 is the first cyclin-dependent kinase inhibitor (CKI) to be identified, and induction of p21 cip1 might cause cell cycle arrest. The p21 cip1 is poised to play an important role in preventing tumor development. Previous findings have demonstrated that p21-null mice was more prone to spontaneous and induced tumorigenesis, and in vivo the ectopic expression of p21 cip1 protected against tumor progression in mice [1] . On the other hand, reduced levels of p21 cip1 transcript have been found in some malignant cells with absence of functional p53, which suggested that low levels of p21 might constitute an advantage in tumor growth [2] . Furthermore, p21 selectively inhibited genes involved in cell-cycle progression, cell division and DNA repair. Some p21-inhibited genes contained E2F or SP1 sites in their promoters, suggesting a highly selective nature of p21 cip1 -involved inhibition partly mediated through transcriptional factors [3] .
Survivin, an anti-apoptotic protein highly expressed in cancer, regulates multiple cellular networks associated with cancer cell viability and prognosis. However, growing reports have suggested that survivin expression is strongly correlated with the proliferation index but not significantly associated with the apoptosis index in carcinoma development [4] . In addition, survivin is expressed during the G2/M phase and in a cell-cycle dependent way. Moreover, survivin expression has been shown to be regulated largely at the transcriptional level. A variety of transcription factors induced by different signaling pathways can activate survivin transcription [5] . Therefore, down-regulating the expression level is an important therapeutic option for breast cancer. In this research, the transcriptional regulation of survivin was analyzed to establish survivin as a target gene for new therapeutic approaches and a novel regulatory mechanism within the survivin promoter was investigated.
In this present study, breast carcinoma cell line MCF7 was treated with epirubicin, which simultaneously caused the accumulation of endogenous p53 and p21 cip1 gene and downregulate the expression of survivin mRNA within 24 hours after treatment. Based on the effects of survivin on cell cycle, it is hypothesized that it may serve as a target candidate for p21 regulation at the transcriptional level.
Therefore, the eukaryotic vector pEGFP-C2-p21 cip1 was stably transfected into MCF7 cells, which overexpressed p21 gene. The changes in the expression levels of p21, p53 and survivin mRNA were determined with RT-PCR to study whether p21 cip1 can inhibit survivin mRNA expression. Consequently, in this particular system, p21 cip1 overexpression could downregulate the expression level of survivin mRNA in a p21-specific manner, but did not completely act at the downstream events of p53 signaling pathway. The effects of p21 cip1 were confirmed by cell cycle phase detection and transcriptional cofactors of p300/CBP, E2F or sp1 activity analysis at the transcriptional level, which are the key regulation factors of survivin expression. These results characterize a novel survivin signaling pathway in cell cycle development in MCF7 cells.
EXPERIMENTAL

Materials and reagents
Dulbecco's Modified Eagle Medium (DMEM), fetal bovine serum (FBS) and G418 were obtained from Gibco BRL. Epirubicin and propidium iodide (PI) were obtained from Sigma Chemical Company. Lipofectamine 2000, Trizol reagent and Hoechst 33342 were purchased from Invitrogen Company. ReverTra Ace-a-first strand cDNA synthesis kit was purchased from TOYOBO Co. (Osaka, Japan). PGEM-T-easy vector system was purchased from Promega Company. Real-time fluorescence quantitative PCR detection kit for GAPDH gene was purchased from ShenYou Biotechnology Co. (Shanghai, China). SyberGreen I and LightCycler analyzer were supplied by Roche Diagnostics.
Epirubicin treatment
MCF7 cell line, a human breast cancer cell line was maintained in DMEM with 10 % FBS, 100 U/mL penicillin and 100 μg/mL streptomycin. Cultures were performed at 37℃ in a 5 % CO 2 atmosphere and passaged every 3 days. For drug treatment, exponentially growing cells were treated with 0.2 μg/mL (final concentration) epirubicin then harvested for total RNA extraction at the indicated time (0 h, 8 h, 12 h, 24 h, 48 h).
Extraction and digestion of transfected plasmids
Bacterial fluid containing pcDNA3 or pcDNA3-p21 plasmid was taken and plasmids were extracted and purified according to the manufacturers' instructions. After dilution, the concentration and purity of the plasmids were measured. pcDNA3-p21 was used as the template, oligonucleotide primers were designed to amplify p21 cip1 open reading frame (ORF) as follows: upper primer 5'-CCG GAA TTC ATG TCA GAA CCG GCT GGG-3'; lower primer 5'-CCG GGA TCC GGG CTT CCT CTT GGA GAA GAT-3'. Using the polymerase chain reaction (PCR), EcoRⅠand a BamHⅠenzymes were added to the 5' and 3' terminus of the cDNA coding for p21 cip1 , respectively. The 495bp fragments of p21 cip1 cDNA were cloned into the expressing vector pEGFP-C2, and positive clones were screened from the transformed DH5. The constructed plasmid (designated as pEGFP-C2-p21 cip1 ) was identified by restriction enzyme analysis and verified by DNA sequencing.
Gene transfection and subclone cell line selection MCF7 cells were seeded onto 6-well plates. When the cell density reached 85 %, pEGFP-C2-p21 cip1 or pEGFP-C2 plasmids were introduced into the MCF7 cells according to the kit instructions of Lipofectamine2000. After transfection for 24 h, the liquid was replaced and cells were cultured for another 48 h. Afterwards, selective medium (G418 at 800 μg/mL) was added for cell screening for about 2 weeks. Once most of the non-transfected cells were dead, the concentration of G418 was decreased to 400μg/mL and maintained for another 2 weeks. After cellular clones' formation, subclones were chosen at random and amplified. The subclone cells expressing GFP-p21 and GFP-neo genes were named as MCF7-p21 and MCF7-C2.
After completion of the 4 weeks selection period, individual clones were isolated and subcultured in selection medium. Subcultured cell was harvested and cellular total RNA was extracted with Trizol reagent kit. Isolated RNA was stored in diethylpyrocarbonate (DEPC)-treated water at 70 ℃. RNA concentration was determined by absorbance readings at 260 nm utilizing an ultraviolet spectrometry. Reverse transcription of RNA was then performed with oligo (dT) 20 priming and ReverTra Ace-a-first strand cDNA synthesis kit.
Cell viability assays
MCF7 cells at logarithmic growth stage was taken, made into cell suspension of 2×10 4 /mL and seeded onto 96-well plates, with each well containing 200 μL of cell suspension and each group having 6 wells. From the first to the fifth day, the cells were stained to detect the cell growth of MCF7 and examine the inhibitory effect of epirubicin alone or adriamycin plus p21 transfection on the cell proliferation of MCF7 cells. Before the termination of the test, 20 μL MTT was added to each well and 4 h later the media were discarded. Then 150 μL DMSO was added to dissolving formazan crystals, and the samples were read on a plate reader at a wavelength of 570 nm to determine their absorbance (A 570 ). All the experiments were repeated three times.
Since the initial cell concentration of samples of the transfection group might differ, in this study, the A 570 value measured at each time point was divided by the corresponding initial A 570 value and the ratios were used for plotting the curve of cell growth trend over time (day) after the transfection. The cell inhibition rate (IR) was calculated by the following formula: IR ＝ (1-average A value of the experimental group/A value of the control group）× 100 %. The inhibition curve over time (day) was prepared.
Real-time quantitative PCR
The primers of p21 cip1 , p53 and survivin were designed and synthesized by Takara life Technique Company, then purified by PAGE. Real-time quantitative PCR, utilizing 2 µl cDNA, was performed using the gene-specific primer, the sequence of primers were listed in Table 1 , and the transcription level of GAPDH gene was confirmed as a housekeeping target. 
Standard curves analysis
In this study, plasmid pEGFP-C2-p21 cip1 , pGEM-T-easy-p53, pGEM-T-easy-survivin were used as standards respectively. pGEM-T vector consisted of p53 or survivin gene PCR product prepared by T-A clone as described in the pGEM-T-easy manual (Promega). The standard concentration was quantitated with ultraviolet spectrometry. 
Flow cytometry
Cell (1 × 10 6 /mL) was harvested by trypsin treatment, washed with cold PBS, and fixed in 70 % ethanol at -20 o C overnight. The next day the cell was also washed twice in cold PBS, then stained with PI solution (50 mg/mL PI, 100 mg/mL RNase, and 0.1 % Triton X-100 in PBS) for 30 min at 4 o C. The stained cell was analyzed for DNA histograms and cell cycle phase distribution by flow cytometry (FACSCalibur, BD Bioscience). G0/G1, S and G2/M phase cell populations were measured according to the program CellQuest.
Apoptosis assessment
Hoechst 33342 is a cell-permeable DNA stain that is excited by ultraviolet light and emits blue fluorescence at 460 to 490 nm. MCF7 cells (2 × 10 5 cells/well in a six-well plate) were treated with epirubicin for 0, 8, 16 and 24 h. After trypsinization, cells were washed with 1X PBS and stained with 3 μg/mL of Hoechst 33342 for 15 min. Stained cells were examined using fluorescence microscope (Olympus, Japan) with an ultraviolet filter.
Transcription factors analysis
cDNA of above transfected groups (MCF7-p21, MCF7-C2 and MCF7 ) were used as templates. Primers for E2F-1, SP1 and p300/CBP were designed using Primer 6.0 software and tested to ensure amplification of single discrete bands with no primer-dimers; the sequence of primers are listed in Table 1 . For control, human housekeeping gene GAPDH was synthesized from the same amount of RNA from respective sources.
All PCR products were analyzed by electrophoresis on 2 ％ agarose gels containing 0.5 mg/L ethidium bromide. The amplified products were visualized and photographed under ultraviolet light, scanned and analyzed by UVP bioimage system.
Statistical analysis
The software SPSS for Windows version 17.0 was used for statistical analysis and each experiment was repeated at least three times. The values were expressed as the mean ± S.D, and then statistical analysis of the data was performed using Student-Newman-Keuls -test and Dunnett's T3 -test. P < 0.05 was considered statistically significant.
RESULTS
Standard RT-PCR curve
Real-time PCR standard curve for the p21 cip1 gene, p53, survivin and GAPDH is Ct p21 ＝-3.649log〔C〕 p21 + 44.83, Ct p53 ＝ -3.597 log〔C〕P53 + 44.08, Ct surviving = -3.378log〔C〕 survivin + 42.53, and Ct GAPDH ＝ -3.86log〔C〕 GAPDH + 46.70 respectively. The Ct values were plotted versus the log of the initial concentration of the positive standards, and the 
P21, p53 and survivin mRNA level after treatment with epirubicin
After MCF7 cells were treated with epirubicin, in comparison with the control group, the mRNA level of p21 cip1 , p53 and survivin are shown in Table 2 . In other words, the level of p21 cip1 mRNA gradually increased within 24 h and increased up to 180.18-fold at 24h over the control group at 0h; on the other hand, survivin mRNA expression was decreased to about 9.37 % of basal level at 24 h. Furthermore, the p21 cip1 mRNA level was almost restored to the baseline level at 48 h after epirubicin treatment. Moreover, the survivin mRNA level was restored 54.87 % of the baseline level.
p21 mRNA level after transfection
MCF7 cell was stably transfected with p21 gene, and the transfection efficiency was determined by real time PCR. Table 3 showed that the expression of p21increased significantly after transfection (F ＝ 9.92，p < 0.05), that is to say, the expression of p21 increased by 2100.11 -and 980.89 -fold in MCF7 and MCF7-C2 over that in the MCF7-p21, respectively. However, the levels of p21 mRNA between MCF7 and MCF7-C2 did not significantly differ (p > 0.05).
Growth curve of MCF7 cells after transfection
MTT assay showed that cell proliferation in the blank control and MCF7-C2 transfection group did not significantly differ at different time points (all p > 0.05) (Figure 2) . To eliminate the possible influence of vectors, the results between the MCF7-p21 and MCF7-C2 groups were statistically compared by match-paired analysis. At 2 days before the culture, the cell growth in MCF7-p21 transfection group gradually became slow but was not significantly different from that of MCF7-C2 transfection group (t = 1.61，p > 0.05）, while on the 3 rd and 4 th days, statistical significance was observed between the two groups (the 3 rd day: t = 4.04, p < 0.01; the 4 th day: t = 6.80, p < 0.01). On the 5 th day, the growth of MCF7-p21 transfection group was stable and showed no significant difference as compared with the previous time points (t = 0.79, p > 0.05). The cell growth in the control group was slow and the proliferation rate was low. No significant difference was found between two groups (t = 1.37, p > 0.05), indicating that p21 gene could inhibit the growth of MCF7 cells during certain time period. 
Effect of p21 gene on p53 or survivin mRNA expression
As shown in Table 2 and Figure 1 , the expression intensities of survivin mRNA in MCF7-p21 cells were significantly decreased compared with those in the other two groups (F = 114.19, both P < 0.01), and was similarly downregulated to 0.54 and 0.59 % relative to the other groups. On the other hand, the combined data indicated that over-expression of p21 was insufficient to cause the changes of p53 gene expression. 
Effect of transcription factors on the mRNA expression after transfection
As shown in Figure 6 , the E2F-1/GAPDH ratio detected with UVP Bioimage System in MCF7-p21 was 0.75±0.04, as well as 1.42 ± 0.09 and 1.56 ± 0.06 in MCF7-C2 and MCF7, respectively, and statistical analysis showed that E2F-1 mRNA down-regulated significantly after transfecting with p21 (p < 0.05); and SP1, one of the most important transcription factor for survivin, in MCF7-p21 was 0.98 ± 0.05, as well as 1.32 ± 0.11 and 1.43 ± 0.15 in MCF7-C2 and MCF7; It showed that p21decreased SP1 mRNA expression. In addition, p300/CBP in MCF7-p21 was 0.18 ± 0.06, as well as 0.98 ± 0.05, 0.95 ±0.19 in MCF7-C2 and MCF7 respectively, which suggest that p300/CBP mRNA also decreased significantly after transfecting with p21 (p < 0.05). 
DISCUSSION
Survivin, a pivotal cancer gene, is increasingly drawing the attention of researchers. It is specifically expressed in some tumors and or fetal tissues and is barely found in normal adult tissues [6] . In the past, research effort was mainly directed at its anti-apoptotic effect. Recently, it is closely related to the cell cycle progression and can promote cell proliferation in breast tumors. Clinically, high level of survivin is associated with lower survival, drug resistance and poor prognosis [7, 8] , suggesting that survivin might be involved in the malignant changes of breast tumors. Therefore, regulation of survivin at the transcription level captivates more and more attention from oncologists.
As an inhibitor of topo-isomerases Ⅰ and Ⅱ, epirubicin can induce DNA damage, activate P53-P21 pathway and down-regulate phosphorylation of RB proteins, thereby causing cell cycle arrest at G 1 phase. It can also induce cell cycle arrest at G 2 phase by down-regulating the expression of Cyclin B1, and inhibiting the phosphorylation of CDC2 and histone H3, thereby suppressing the growth of tumor cells [9, 10] .
In this study, human breast carcinoma cell line MCF7 was treated with epirubicin, which is the most efficient chemotherapy agent in the clinical treatment of breast cancer [11] , and it inhibited the growth of MCF7 cells to some extent. At 24 and 48 h after the treatment, the expression of survivin mRNA was lower than that of the untreated group but no significant difference was found between two groups at the two time points. Furthermore, the level of p21 mRNA was increased gradually and reached the highest level at 24 h after treatment with epirubicin. When the p21 mRNA levels were almost restored to baseline levels at 48 h after epirubicin treatment, the survivin mRNA levels was restored to approximately 54.87 % of the baseline level, which indicated that p21 inhibited survivin expression at the transcription level directly or indirectly and epirubicin may be simultaneously involved in inhibiting survivin gene expression at transcription level.
Genotoxic agents, such as adriamycin, can specifically inactivate survivin by activating P53 signal pathway, thereby inhibiting its expression. Hoffman et al [12] , by analyzing the start codon of survivin, found that inhibition of survivin transcription was achieved by the interaction of down-stream target molecules of wild-type p53. The p21 protein, a cyclin-dependent protein kinase inhibitor, is an important tumor suppressor gene of down-stream target molecules of wildtype p53 and the biological functions of p53 requires the help of p21. p21 gene is highly conservative and rarely mutates in tumorigenesis. As a down-stream molecule, the broad-spectrum mutation of p53 gene may lead to p21cip1 reduced expression or absence of the expression, thereby inhibiting its functions and loss of p21 functions was highly associated with some pre-cancerous changes, suggesting that p21 might outperform p53 as a tumor suppressor gene [13] . In this research, we investigated whether p21 cip1 is involved in inhibiting survivin expression at the transcription level directly or indirectly, using an extrinsic p21 cip1 gene was transfected into MCF7 breast cancer cells, containing wild-type p53 and the normal biological functions of p53.
After transfection treatment, MCF7 cells which induced its overexpression and the expression levels of p21 mRNA inMCF7, MCF7-C2 and MCF7-p21 groups were 12.41 ± 3.14 copies/mL, 26.57 ± 7.95 copies/mL, and 26062.35 ± 18861.58 copies/mL respectively, whereas the level of survivin mRNA in MCF7, MCF7-C2 and MCF7-p21 groups was 116.71 ± 62.02, 109.32 ± 19.56 and 0.64 ± 0.14 respectively. The results indicated that p21 overexpression could inhibit the expression of survivin at transcriptional level. Flow cytometry revealed that the quantity of cells in G0/G1 was remarkably increased accompanied with the decreasing number of S or G2/M cells due to p21 overexpression, but its overexpression did not induce the apoptosis of MCF7 cells observed by Hoechst33342 staining. It suggested that survivin could be characterized by cell cycle dependent expression, which is mainly expressed in G2/M phase. It is speculated that p21 might down-regulate the expression of survivin gene through cell cycle arrest in G0/G1 phase to some extent.
Because p21 might negatively regulate the expression of survivin gene at the transcription level through cell cycle arrest in G0/G1 phase, part of transcription factors at the promoter region of survivin gene were inhibited by overexpression of p21. Several transcription factor sites have been found at the promoter region of survivin gene, for example, Sp1, E2F and NF-κB sites [14] . RT-PCR demonstrated that p21 overexpression could down-regulate the expression level of E2F-1, as one of E2F family transcription factors. p21 overexpression could down-regulate the expression level of SP1, as one of the most important transcription factors for survivin [14] . Therefore, p21 might negatively regulate the expression of survivin gene at the transcription level partially by inhibiting the expression levels of E2F-1 and SP 1 [15, 16] .
Recent studies have demonstrated that the acetylation state of histones exerts a major influence on transcriptional activity of survivin gene, and decreases histone acetylases activity is frequently involved in transcriptional repression [17] . In this study, p21 overexpression could also inhibiting the activity of histone acetyltransferases (HAT) p300/CBP by suppressing its expression at transcription levels. p300/CBP can transfer an acetyl group to the eamino group of a lysine residue in the NH 2 -termination of histone H3, and in this respect lead to the alteration of chromatin structure and affect access of transcription factors to nucleosomal DNA [18] .
Additionally, p300/CBP can be recruited to promoter of survivin gene by a large number of DNA-binding proteins and stimulate gene expression either through their inherent HAT activity or through its ability to interact with other coactivators and components of the basal transcriptional machinery [19] . Zhu N et al [20] reported that repression of survivin gene expression could result from suppression of histone acetylation of the promoter in the wildtype p53-dependent manner.
CONCLUSION
Based on the findings of the present study, it appears conceivable that p21 cip1 may negatively regulate the expression of survivin gene partially through inhibiting the expression level of HAT. 
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